Skip to content
Entrada Therapeutics, co-founded by Dr. Pei in 2016, was recently launched publicly with $59M series A financing with best in-class biotech veterans/innovators and leading biotech investors. Entrada’s technology enables the intracellular delivery of cargo that are not cell-permeable using pioneering research from the Pei group. Congratulations Dehua! (Press Releases)
Jin and Hui successfully defended their Ph.D thesis! Congratulations Dr. Jin Wen and Dr. Hui Liao!!
Jahan Cooper successfully defended his Master’s thesis, congratulations!!
Brenna Collins joined Texas A&M University to pursue graduate studies. We wish you all the very best Brenna!